In focus
Latest feed
The Weight-Loss Drug Wars: Novo Nordisk Eyes Vials for Wegovy in High-Stakes Battle
FDA Approval for Cytokinetics' Aficamten: A Scientific Triumph, But Wall Street Remains Wary
Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum
The Great Weight Race: Can New Contenders Navigate the Treacherous Path of Next-Gen Obesity Drugs?
